Follow
Gaurav Joshi
Title
Cited by
Cited by
Year
Emergence of influenza A (H1N1) pdm09 genogroup 6B and drug resistant virus, India, January to May 2015
M Parida, PK Dash, JS Kumar, G Joshi, K Tandel, S Sharma, A Srivastava, ...
Eurosurveillance 21 (5), 30124, 2016
422016
Microneedles coated with peanut allergen enable desensitization of peanut sensitized mice
AK Shakya, RSJ Ingrole, G Joshi, MJ Uddin, S Anvari, CM Davis, HS Gill
Journal of controlled release 314, 38-47, 2019
382019
Mosquito saliva induced cutaneous events augment Chikungunya virus replication and disease progression
A Agarwal, G Joshi, DP Nagar, AK Sharma, D Sukumaran, SC Pant, ...
Infection, Genetics and Evolution 40, 126-135, 2016
382016
Molecular epidemiology and complete genome characterization of H1N1pdm virus from India
S Sharma, G Joshi, PK Dash, M Thomas, TN Athmaram, JS Kumar, ...
PLoS One 8 (2), e56364, 2013
272013
M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets
RSJ Ingrole, W Tao, G Joshi, HS Gill
Vaccine 39 (34), 4800-4809, 2021
182021
Assessment of in vitro antiviral activity of Ocimum sanctum (Tulsi) against pandemic Swine flu H1N1 virus infection
G Joshi, S Sharma, J Acharya, M Parida
World Res. J. Antimicribial Agents 3 (1), 062-067, 2014
92014
Development of a SYBR green I-based quantitative RT-PCR for Ross River virus: Application in vector competence studies and antiviral drug evaluation
PK Dash, A Agarwal, S Sharma, A Saha, G Joshi, N Gopalan, ...
Journal of virological methods 234, 107-114, 2016
82016
Tyrosine-Based Cross-Linking of Peptide Antigens to Generate Nanoclusters with Enhanced Immunogenicity: Demonstration Using the Conserved M2e Peptide of Influenza A
LR Wilks, G Joshi, MR Grisham, HS Gill
ACS infectious diseases 7 (9), 2723-2735, 2021
62021
Delivery of gold nanoparticle-conjugated M2e influenza vaccine in mice using coated microneedles
LD Nesovic, CJ Roach, G Joshi, HS Gill
Biomaterials Science 11 (17), 5859-5871, 2023
52023
Bifunctional siRNA containing immunostimulatory motif enhances protection against pandemic H1N1 virus infection
G Joshi, PK Dash, A Agarwal, S Sharma, M Parida
Current Gene Therapy 15 (5), 492-502, 2015
42015
Mapping and Immunological Response of Immunodominant B and T cell Epitopes of E2 Glycoprotein of Chikungunya Virus
PK Nagar, S Pradhan, P Verma, G Joshi, A Singh, DN Rao
MOJ Immunol 4 (1), 1-10, 2016
32016
Laboratory Investigation and Molecular Epidemiology of H1N1pdm Virus 2012-2013 from India
S Shashi, J Gaurav, K Paban Dash, MM Parida
J Phylogen Evolution Biol 3 (139), 2, 2015
32015
Peptide Cross-Linking Using Tyrosine Residues Facilitated by an Exogenous Nickel–Histidine Complex: A Facile Approach for Enhancing Vaccine-Specific Immunogenicity
LR Wilks, G Joshi, SM Kang, BZ Wang, HS Gill
ACS Infectious Diseases 8 (12), 2389-2395, 2022
22022
Comparison of Different Stabilizing Agents and Antigen Attachment Methods on Iron Oxide Nanoparticles for Vaccination
C Roach, G Joshi, HS Gill
Biomedical Materials & Devices 2 (1), 485-497, 2024
2024
Coronavirus Vaccine
HS Gill, G Joshi
US Patent App. 18/006,097, 2023
2023
Using CRISPR Cas13a to Combat the Flu Virus at the Genetic Level: A New Approach to Flu Treatment
M Parker, G Joshi, H Gill
2019 AIChE Annual Meeting, 2019
2019
Design, synthesis and antiviral evaluation of phenyl piperazine containing benzyl trizole derivatives against pandemic swine flu (H1N1) influenza virus
G Joshi, M Parida
International Conference on Flu 4 (2), http://dx.doi.org/10.4172/2161-0517.S1.0, 2015
2015
Souvenir and Abstracts
R Rabindran, G Karthikeyan, VG Malathi, SK Manoranjitham, ...
XXIII National Conference-VIROCON, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–18